Literature DB >> 21862223

Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected.

Alexander Lischke1, Christoph Berger, Kristin Prehn, Markus Heinrichs, Sabine C Herpertz, Gregor Domes.   

Abstract

Previous studies have shown that oxytocin improves the encoding and recognition of facial expressions, which has been proposed to be mediated by an increased exploration of the eye region during face processing. In the present study, we used eye tracking to assess visual attention to the eye region while participants performed a dynamic facial emotion recognition task. In a double-blind, placebo-controlled between-subjects design participants received 24 IU intranasal oxytocin (n = 23) or a placebo (n = 24). Although oxytocin administration had no effect on participants' visual scanning of emotional faces, it generally enhanced recognition performance, as the oxytocin group recognized emotional expressions at lower intensity levels. These findings suggest that oxytocin-induced improvement of facial emotion recognition is independent of modulations in overt visual attention. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862223     DOI: 10.1016/j.psyneuen.2011.07.015

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  67 in total

1.  A Double-Blind Placebo Controlled Study of Intranasal Oxytocin's Effect on Emotion Recognition and Visual Attention in Outpatients with Emotional Disorders.

Authors:  Lauren A Rutter; Daniel J Norton; Bonnie S Brown; Timothy A Brown
Journal:  Cognit Ther Res       Date:  2018-11-03

Review 2.  Oxytocin for the treatment of drug and alcohol use disorders.

Authors:  Mary R Lee; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

3.  Epigenetic modification of OXT and human sociability.

Authors:  Brian W Haas; Megan M Filkowski; R Nick Cochran; Lydia Denison; Alexandra Ishak; Shota Nishitani; Alicia K Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

Review 4.  Empathy as a Concept from Bench to Bedside: A Translational Challenge.

Authors:  Nazan Uysal; Ulaş M Çamsari; Mehmet ATEş; Sevim Kandİş; Aslı Karakiliç; Gamze B Çamsari
Journal:  Noro Psikiyatr Ars       Date:  2019-11-28       Impact factor: 1.339

5.  Plasma oxytocin and vasopressin levels in young and older men and women: Functional relationships with attachment and cognition.

Authors:  Gabriela Plasencia; Joerg M Luedicke; Hossein P Nazarloo; C Sue Carter; Natalie C Ebner
Journal:  Psychoneuroendocrinology       Date:  2019-08-31       Impact factor: 4.905

6.  Gender differences in oxytocin-associated disruption of decision bias during emotion perception.

Authors:  Spencer K Lynn; Elizabeth A Hoge; Laura E Fischer; Lisa Feldman Barrett; Naomi M Simon
Journal:  Psychiatry Res       Date:  2014-04-26       Impact factor: 3.222

7.  Effects of chronic oxytocin on attention to dynamic facial expressions in infant macaques.

Authors:  Lisa A Parr; Jenna M Brooks; Trina Jonesteller; Shannon Moss; James O Jordano; Thomas R Heitz
Journal:  Psychoneuroendocrinology       Date:  2016-08-31       Impact factor: 4.905

Review 8.  Intranasal oxytocin effects on social cognition: a critique.

Authors:  Simon L Evans; Olga Dal Monte; Pamela Noble; Bruno B Averbeck
Journal:  Brain Res       Date:  2013-11-14       Impact factor: 3.252

Review 9.  Oxytocin and postpartum depression: delivering on what's known and what's not.

Authors:  Sohye Kim; Timothy A Soeken; Sara J Cromer; Sheila R Martinez; Leah R Hardy; Lane Strathearn
Journal:  Brain Res       Date:  2013-11-14       Impact factor: 3.252

10.  Effects of intranasal oxytocin prior to encoding and retrieval on recognition memory.

Authors:  Anne Weigand; Melanie Feeser; Matti Gärtner; Emily Brandt; Yan Fan; Philipp Fuge; Heinz Böker; Malek Bajbouj; Simone Grimm
Journal:  Psychopharmacology (Berl)       Date:  2013-01-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.